(AGENPARL) – LONDON (UNITED KINGDOM), ven 18 giugno 2021 Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Meningitis, Meningococcal, Date of authorisation: 20/04/2012, Revision: 33, Status: Authorised

Fonte/Source: https://www.ema.europa.eu/en/medicines/human/EPAR/nimenrix